ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.820,48
0,75%
S&P 500
5.214,08
0,51%
Dow Jones
39.387,76
0,85%
Euro vs US Dollar
1,07765
-0,05%
Bitcoin
62.952,66
-0,15%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE
  6. Gt Biopharma Inc (0RU9)

  7. Gt Biopharma Inc (0RU9) News

0RU9

Gt Biopharma (0RU9)

Gt Biopharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:0RU9
DatumZeitQuelleÜberschriftSymbolFirma
12/09/201913h30PR Newswire (US)GT Biopharma Announces FDA Notification of Commencement of Enrollment in Human GTB-3550 Trike™ Phase i/ii Clinical TrialLSE:0RU9Gt Biopharma Inc
12/09/201913h30PR Newswire (US)GT Biopharma Announces FDA Notification of Commencement of Enrollment in Human GTB-3550 Trike™ Phase i/ii Clinical TrialLSE:0RU9Gt Biopharma Inc
13/06/201913h30PR Newswire (US)GT Biopharma GTB-1550LSE:0RU9Gt Biopharma Inc
13/06/201913h30PR Newswire (US)GT Biopharma GTB-1550LSE:0RU9Gt Biopharma Inc
29/05/201913h30PR Newswire (US)GT Biopharma GTB-1550 PHASE I-II Results to be Published in Conjunction With 2019 ASCO Meeting May 31 - June 4 in ChicagoLSE:0RU9Gt Biopharma Inc
29/05/201913h30PR Newswire (US)GT Biopharma GTB-1550 PHASE I-II Results to be Published in Conjunction With 2019 ASCO Meeting May 31 - June 4 in ChicagoLSE:0RU9Gt Biopharma Inc
26/03/201912h30PR Newswire (US)GT Biopharma Announces Completion of Management RestructuringLSE:0RU9Gt Biopharma Inc
30/08/201814h00PR Newswire (US)GT Biopharma's Chairman and Chief Executive Officer Raymond W Urbanski, M.D., Ph.D Provides Insight Into the Impact of the Re...LSE:0RU9Gt Biopharma Inc
29/08/201813h45PR Newswire (US)GT Biopharma's Chairman and Chief Executive Officer Provides Insight Into the Impact of the Recent Affimed/Roche-Genetech Col...LSE:0RU9Gt Biopharma Inc
24/08/201814h00PR Newswire (US)GT Biopharma Announces the Appointment of David Cardino, CPA, MBA as Vice President of FinanceLSE:0RU9Gt Biopharma Inc
14/08/201814h00PR Newswire (US)GT Biopharma Announces GTBP CEO, Dr. Raymond Urbanski, to Make Presentation at the 2018 Wedbush PacGrow Healthcare ConferenceLSE:0RU9Gt Biopharma Inc
25/07/201814h00PR Newswire (US)GT Biopharma Announces the Addition of Dr. John N. Bonfiglio to its Board of DirectorsLSE:0RU9Gt Biopharma Inc
19/07/201814h00PR Newswire (US)GT Biopharma Inc. Announces Agreement with a Major Pharmaceutical Company to Study its Drug Candidate OXS-1550 in Combination...LSE:0RU9Gt Biopharma Inc
05/06/201814h00PR Newswire (US)GT Biopharma Announces Voluntary Lock-Up Agreements With Insiders Covering Over 52% of Outstanding SharesLSE:0RU9Gt Biopharma Inc
14/05/201813h45PR Newswire (US)Gt Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the CompanyLSE:0RU9Gt Biopharma Inc
26/04/201814h30PR Newswire (US)Seasoned Financial Executive Federica O'Brien Joins GT Biopharma's Board of DirectorsLSE:0RU9Gt Biopharma Inc
24/04/201815h15PR Newswire (US)Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of DirectorsLSE:0RU9Gt Biopharma Inc
29/03/201815h05PR Newswire (US)GT Biopharma Inc. Announces >50% Enrollment in Proof-Of-Concept Clinical Trial For Its Novel Treatment For Motion SicknessLSE:0RU9Gt Biopharma Inc
13/02/201813h45PR Newswire (US)GT Biopharma Announces Dr. Jeffrey Miller, Renowned NK Cell Cancer Specialist, Will Present at Cell Therapy SymposiaLSE:0RU9Gt Biopharma Inc
24/01/201814h39PR Newswire (US)GT Biopharma, Inc. Issues Letter to ShareholdersLSE:0RU9Gt Biopharma Inc
18/12/201716h27PR Newswire (US)GT Biopharma, Inc. Files Application for NASDAQ Capital Market ListingLSE:0RU9Gt Biopharma Inc
 Showing the most relevant articles for your search:LSE:0RU9

Kürzlich von Ihnen besucht

DBI
DAX
DAX
CCOM
US500
US 500
COIN
SOLUSD
Solana
TG
DBK
Deutsche Bank
NYSE
MCD
McDonalds
NYSE
KO
Coca Cola
TG
BAS
BASF
TG
TUI1
Tui
PM
XAUUSD
Gold vs US Dollar
USOTC
RHHBY
Roche (QX)
NASDAQ
NVDA
NVIDIA
TG
ALV
Allianz
FX
EURUSD
Euro vs US Dollar
USOTC
BNPQY
BNP Paribas (QX)
DBI
MDAX
MDAX
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten